Biotech Values

[ghmm]

FYI
Its Phase 1 I believe not sure on the merits of it



http://www.virexx.com/product/hepavaxb.asp


Hepavaxx B


Product Overview

HepaVaxx B is a Chimigen™ therapeutic vaccine developed at the ViRexx research labs for the treatment of chronic hepatitis B viral infections.

HepaVaxx B consists of a recombinant chimeric molecule containing the elements of both a hepatitis B viral antigen and a xenotypic antibody. The molecule is designed to target a particular set of cells that play a dominant role in the body's immune system. Validation of the uptake, processing and activation of the cells responsible for modulating the immune response was conducted by ViRexx using specialized assay systems developed by ViRexx. The selected Chimigen™ vaccine is expressed in insect cells which produce the desired product in large quantities under appropriate culture conditions.